New Cancer Drug Approvals Linked to Drop in Mortality
New cancer drugs approved between 2000 and 2016 associated with 1,291,769 fewer related deaths in the U.S.
Medicare Outpatient Premium to Rise
Monthly premium for outpatient care will rise by $3.90 next year
Review: Nearly One in Five With SARS-CoV-2 Has GI Manifestations
Sixteen percent of COVID-19 cases may only present with gastrointestinal symptoms, which include nausea, vomiting, diarrhea
Considerable Decreases Seen in Health Care Use During COVID-19
Reductions reported in colonoscopies, mammograms, child vaccines, in-person office visits; telemedicine service use up in March, April 2020
Mortality Down for Cancer Patients With Medicaid Expansion
Mortality reduced for patients with newly diagnosed breast, colorectal, lung cancers, mediated by earlier stage of diagnosis
~65 Percent of Office-Based Doctors Can ID Patients in Need of Follow-Up
More primary care physicians and those with an EHR system have computerized capability to ID patients due for preventive, follow-up care
USPSTF Issues Draft Recommendation for CRC Screening
Benefit substantial for adults aged 50 to 75 years; benefit moderate for adults aged 45 to 49 years
Decrease Seen in Non-COVID-19-Related Hospitalizations at Peak
Caseload of common medical emergencies, including acute MI, ischemic stroke also decreased
Rurality, Income Impact Stage at Diagnosis, Mortality in Liver Cancer
Patients from rural regions, lower-income households have more advanced stage at diagnosis of HCC
